Reversible Neurological Adverse Reaction to Apixaban

Rodrigues Cernadas, Eduardo and Dionisio, Catarina and Estevão, Dália and Vicente, Leopoldina (2021) Reversible Neurological Adverse Reaction to Apixaban. European Journal of Case Reports in Internal Medicine, 8 (4). pp. 1-3. ISSN ISSN: 2284-2594

1739-Article Text-21930-1-10-20210414.pdf - Published Version

Download (190kB) | Preview
Official URL:


Prescriptions for the novel oral anticoagulant factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) have equalled or exceeded those for vitamin K antagonists in many clinical settings requiring chronic anticoagulation, and those of injectable heparins for deep vein thrombosis prophylaxis. The authors report the case of an 80-year-old woman followed by her cardiologist for permanent atrial fibrillation who was prescribed apixaban. Within a few days the patient developed neurological symptoms of imbalance and non-vertiginous dizziness, headache, confusion/disorientation and asthenia. Her symptoms began to resolve after the drug was stopped, with return to baseline function within 72 h. The plasma concentration of apixaban was 4 times higher than the laboratory upper limit of normal. Symptoms did not recur when the patient was switched to rivaroxaban therapy.

Item Type: Article
Uncontrolled Keywords: Apixaban, neurological symptoms, adverse drug reaction
Subjects: 600 Tecnologia - Scienze applicate
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Marina Spanti
Date Deposited: 21 Dec 2021 15:04
Last Modified: 21 Dec 2021 15:04

Actions (login required)

View Item View Item